Identification of Pathways and Targets in Post-influenza Invasive Pulmonary Aspergillosis
流感后侵袭性肺曲霉病的途径和靶标的确定
基本信息
- 批准号:10063634
- 负责人:
- 金额:$ 6.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAllergic Bronchopulmonary AspergillosisAntiviral AgentsArchitectureAspergillosisAspergillusAspergillus fumigatusBacterial PneumoniaCell physiologyCellsCellular AssayCessation of lifeClinicalCritical IllnessDNA Sequencing FacilityDataDevelopmentDiseaseFutureGenesGenomicsGoalsHealthHematopoietic Stem Cell TransplantationHeterogeneityHost DefenseHumanImmuneImmune TargetingImmune responseImmune systemImmunocompromised HostIndividualInfectionInflammationInfluenzaInfluenza A virusInhalationInheritedInterferonsInvadedInvestigationKnowledgeLaboratoriesLearningLeukocytesLifeLungLung TransplantationLung infectionsMapsMethodsModelingMolecularMorbidity - disease rateMusMycosesNeutropeniaPTPRC genePathway interactionsPatientsPlayPopulationPredispositionPreparationRegulator GenesReproduction sporesResearchResearch Project GrantsResearch SupportResolutionRespiratory SystemRespiratory Tract InfectionsRiskRisk FactorsSamplingSecondary toSignal PathwaySignal TransductionStructure of parenchyma of lungTherapeutic InterventionUniversitiesacquired immunodeficiencybasecell typeexperienceexperimental studyfungusinflammatory milieuinfluenza epidemicmortalitymouse modelnovel therapeutic interventionpathogenic funguspreventrespiratoryresponsesingle cell sequencingsingle-cell RNA sequencingsuperinfectiontranscriptometranscriptomics
项目摘要
PROJECT SUMMARY
Fungal pathogens are a serious threat to human health. Invasive pulmonary aspergillosis (IPA) is a severe, life-
threatening disease that occurs when Aspergillus fumigatus (AF) spores are inhaled into the respiratory tract
and invade airway or lung tissue. More than 200,000 cases of invasive aspergillosis occur each year. A newly
identified risk factor for IPA in critically ill patients is influenza infection. Influenza is a common respiratory illness
that affects 5-20% of the population each year. Our long-term goal is to develop novel therapeutic interventions
for use in clinical settings to prevent morbidity and mortality from IPA. The focus of this application is to identify
cell signaling pathways that increase susceptibility to invasive fungal disease following influenza infection. We
hypothesize that preceding influenza A infection inhibits leukocyte responses against secondary Aspergillus
fumigatus infection through the induction of IFN, leading to invasive pulmonary aspergillosis. Our research aims
include 1) To characterize the gene regulatory architecture of leukocytes at a single cell resolution during post-
influenza invasive pulmonary aspergillosis. We will perform single cell RNA sequencing on CD45+ immune cells
collected from lung tissue from (1) wild-type and (2) IFN -/- mice infected with aspergillus, influenza, and super-
infected with influenza followed by aspergillus.
项目摘要
真菌病原体是对人类健康的严重威胁。侵入性肺曲霉菌病(IPA)是一种严重的生活 -
当曲霉(AF)孢子遗传到呼吸道中时,发生威胁性疾病
并入侵气道或肺组织。每年发生超过200,000例侵入性曲霉病。一个新的
危重患者的IPA识别危险因素是影响力感染。流感是常见的呼吸道疾病
每年影响5-20%的人口。我们的长期目标是开发新颖的治疗干预措施
用于在临床环境中使用以防止IPA发病和死亡率。该应用程序的重点是确定
影响力感染后增加对浸润性真菌疾病的敏感性的细胞信号通路。我们
假设前面的影响影响白细胞反应对第二曲曲霉的反应
通过诱导IFN感染富玛曲子,导致浸润性肺曲霉病。我们的研究目的
包括1)表征白细胞在单个细胞分辨率下的基因调节结构
影响肺曲霉病。我们将在CD45+免疫细胞上执行单细胞RNA测序
从(1)野生型和(2)IFN-/ - 小鼠从肺组织中收集,感染了曲霉,有影响力和超级
感染了影响力,然后是曲霉。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Keven Mara Robinson其他文献
Keven Mara Robinson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Keven Mara Robinson', 18)}}的其他基金
Influenza Attenuates Innate Pulmonary Host Defense against Invasive Pulmonary Aspergillosis
流感削弱肺宿主对侵袭性肺曲霉病的先天防御
- 批准号:
10835161 - 财政年份:2021
- 资助金额:
$ 6.81万 - 项目类别:
Influenza Attenuates Innate Pulmonary Host Defense against Invasive Pulmonary Aspergillosis
流感削弱肺宿主对侵袭性肺曲霉病的先天防御
- 批准号:
10449394 - 财政年份:2021
- 资助金额:
$ 6.81万 - 项目类别:
Influenza Attenuates Innate Pulmonary Host Defense against Invasive Pulmonary Aspergillosis
流感削弱肺宿主对侵袭性肺曲霉病的先天防御
- 批准号:
10651832 - 财政年份:2021
- 资助金额:
$ 6.81万 - 项目类别:
Influenza Attenuates Innate Pulmonary Host Defense against Invasive Pulmonary Aspergillosis
流感削弱肺宿主对侵袭性肺曲霉病的先天防御
- 批准号:
10297248 - 财政年份:2021
- 资助金额:
$ 6.81万 - 项目类别:
Identification of Pathways and Targets in Post-influenza Invasive Pulmonary Aspergillosis
流感后侵袭性肺曲霉病的途径和靶标的确定
- 批准号:
10224339 - 财政年份:2020
- 资助金额:
$ 6.81万 - 项目类别:
Role of IL-33 in Influenza and Staphylococcus aureus Co-infection
IL-33 在流感和金黄色葡萄球菌合并感染中的作用
- 批准号:
9320979 - 财政年份:2016
- 资助金额:
$ 6.81万 - 项目类别:
Role of IL-33 in Influenza and Staphylococcus aureus Co-infection
IL-33 在流感和金黄色葡萄球菌合并感染中的作用
- 批准号:
9751941 - 财政年份:2016
- 资助金额:
$ 6.81万 - 项目类别:
相似海外基金
The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity
SARS-CoV-2 免疫失调对抗真菌免疫的影响
- 批准号:
10658355 - 财政年份:2023
- 资助金额:
$ 6.81万 - 项目类别:
Mechanistic Investigation of Gut Mycobiota in the Regulation of Lung Immunity and Disease
肠道菌群调节肺部免疫和疾病的机制研究
- 批准号:
10793853 - 财政年份:2023
- 资助金额:
$ 6.81万 - 项目类别:
Genetic Determinants of Aspergillus host-pathogen interactions
曲霉菌宿主-病原体相互作用的遗传决定因素
- 批准号:
10724816 - 财政年份:2023
- 资助金额:
$ 6.81万 - 项目类别:
Lymph node stromal cells coordinate immune cell environments during Aspergillus fumigatus infection
烟曲霉感染期间淋巴结基质细胞协调免疫细胞环境
- 批准号:
10751936 - 财政年份:2023
- 资助金额:
$ 6.81万 - 项目类别:
Development of a novel broad spectrum antifungal therapeutic targeting Glycosylphosphatidylinositol (GPI) biosynthesis and cell wall biogenesis
开发一种针对糖基磷脂酰肌醇 (GPI) 生物合成和细胞壁生物合成的新型广谱抗真菌治疗药物
- 批准号:
10759723 - 财政年份:2023
- 资助金额:
$ 6.81万 - 项目类别: